Cash and Cash Equivalents and Short-Term Investments (Tables)

3 Months Ended

Mar. 31, 2024

Investments, Debt and Equity Securities [Abstract]

Cash, Cash Equivalents and Investments

	March 31,
	2024		2023
Cash and Cash Equivalents	$	172,551	$	192,826
Restricted Cash - Current(1)	44,227		45,797
Restricted Cash - Non-current(1)	—		8,220
Cash and Cash Equivalents and Restricted Cash	$	216,778	$	246,843

(1) Restricted Cash - Current is included in Other Current Assets in the accompanying Consolidated Balance Sheets. Restricted Cash - Non-current is included in Other Noncurrent Assets, net in the accompanying Consolidated Balance Sheets.

The components of cash and cash equivalents and restricted cash as of December 31, 2023 and 2022 are disclosed in Note 6 in the Notes to the Consolidated Financial Statements included in our Form 10-K for the year ended December 31, 2023, filed with the Securities and Exchange Commission on February 9, 2024.

Debt Securities, Available-for-Sale

The Company's investments in available-for-sale securities are as follows:

	March 31, 2024
					Gross Unrealized
	Amortized Cost		Allowance for Credit Losses		Gains		Losses		Fair Value
U.S. Treasury Securities	$	82,642	$	—	$	—	$	(59)	$	82,583

	December 31, 2023
					Gross Unrealized
	Amortized Cost		Allowance for Credit Losses		Gains		Losses		Fair Value
U.S. Treasury Securities	$	81,829	$	—	$	103	$	—	$	81,932